Abstract
Background: Preeclampsia is characterized by the onset of hypertension beyond 20 weeks of pregnancy, in addition to proteinuria and/or end-organ dysfunction, including high liver enzymes, elevated serum creatinine, thrombocytopenia, pulmonary edema, new-onset headache not responding to medications and visual disturbances. The study aimed to assess maternal and perinatal outcomes between expectant (delivery 48 h after admission) and aggressive management (delivery within 48 h) in patients with preeclampsia according to the newly defined 2020 American College of Obstetrics and Gynecology preeclampsia guideline to determine the optimal management approach.